Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmine Giorgio

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|October 23, 2023
Drug discovery: In silico dry data can bypass biological wet data?Massimiliano Tognolini, Alessio Lodola, Carmine Giorgio
Expert Opinion on Therapeutic Targets|March 22, 2020
Ephrin or not? Six tough questions on Eph targetingCarmine Giorgio, Ilaria Zanotti, Alessio Lodola, et al.
Expert Opinion on Therapeutic Patents|September 11, 2024
Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018-present)Massimiliano Tognolini, Francesca Romana Ferrari, Alfonso Zappia, et al.
European Journal of Medicinal Chemistry|August 7, 2017
Targeting Eph/ephrin system in cancer therapyAlessio Lodola, Carmine Giorgio, Matteo Incerti, et al.
Drug Discovery Today|December 3, 2013
Therapeutic perspectives of Eph-ephrin system modulationMassimiliano Tognolini, Iftiin Hassan-Mohamed, Carmine Giorgio, et al.
Fitoterapia|October 15, 2009
Ocotea quixos Lam. essential oil: in vitro and in vivo investigation on its anti-inflammatory propertiesVigilio Ballabeni, Massimiliano Tognolini, Carmine Giorgio, et al.
International Immunopharmacology|January 11, 2026
Target validation of natural compounds: Perillaldehyde case studyAndrea Blesio, Carmine Giorgio, Stefano Sala, et al.
Plos One|April 12, 2011
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activationCarmine Giorgio, Iftiin Hassan Mohamed, Lisa Flammini, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile AcidsLorenzo Guidetti, Riccardo Castelli, Laura Scalvini, et al.
Chemmedchem|October 12, 2013
Target hopping as a useful tool for the identification of novel EphA2 protein-protein antagonistsMassimiliano Tognolini, Matteo Incerti, Daniele Pala, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|October 23, 2023
Drug discovery: In silico dry data can bypass biological wet data?Massimiliano Tognolini, Alessio Lodola, Carmine Giorgio
Expert Opinion on Therapeutic Targets|March 22, 2020
Ephrin or not? Six tough questions on Eph targetingCarmine Giorgio, Ilaria Zanotti, Alessio Lodola, et al.
Expert Opinion on Therapeutic Patents|September 11, 2024
Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018-present)Massimiliano Tognolini, Francesca Romana Ferrari, Alfonso Zappia, et al.
European Journal of Medicinal Chemistry|August 7, 2017
Targeting Eph/ephrin system in cancer therapyAlessio Lodola, Carmine Giorgio, Matteo Incerti, et al.
Drug Discovery Today|December 3, 2013
Therapeutic perspectives of Eph-ephrin system modulationMassimiliano Tognolini, Iftiin Hassan-Mohamed, Carmine Giorgio, et al.
Fitoterapia|October 15, 2009
Ocotea quixos Lam. essential oil: in vitro and in vivo investigation on its anti-inflammatory propertiesVigilio Ballabeni, Massimiliano Tognolini, Carmine Giorgio, et al.
International Immunopharmacology|January 11, 2026
Target validation of natural compounds: Perillaldehyde case studyAndrea Blesio, Carmine Giorgio, Stefano Sala, et al.
Plos One|April 12, 2011
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activationCarmine Giorgio, Iftiin Hassan Mohamed, Lisa Flammini, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile AcidsLorenzo Guidetti, Riccardo Castelli, Laura Scalvini, et al.
Chemmedchem|October 12, 2013
Target hopping as a useful tool for the identification of novel EphA2 protein-protein antagonistsMassimiliano Tognolini, Matteo Incerti, Daniele Pala, et al.
Pageof 6